Zaghloul M S, El Baradie M, Abdel-Fatah S, Taher A, Shalaan M
Radiation Oncology Dept., National Cancer Institute, Cairo.
Gulf J Oncolog. 2007 Jul(2):47-54.
To determine the working independent prognostic factors and the prognostic index of adenocarcinoma of the urinary bladder. The effect of adding postoperative radiotherapy to radical cystectomy on this prognostic index was also investigated.
Two hundred and sixteen patients having adenocarcinoma of the urinary bladder were treated with radical cystectomy and pelvic lymphadenectomy with (82 patients) or without (134) postoperative radiotherapy. Postoperative radiotherapy (PORT) was given to the whole pelvis in a dose of 50 Gy/25 fractions over 5 weeks, and started 4-10 weeks after surgery.
The 5-year disease-free survival rate was 44 +/- 4% for the whole group. Postoperative radiotherapy improved the disease-free survival significantly from 33 +/- 6% for cystectomy alone Introduction to 58 +/- 6% for PORT patients (P = 0.002). The independent prognostic factors for DFS were the pathological stage, histological subtypes, nodal involvement and the addition of postoperative radiotherapy. The stratification of patients using prognostic indices according to the pathological findings produces identifiable prognostic groups. Postoperative radiotherapy improved the DFS significantly in the intermediate and high risk indices (p = 0.0004 and 0.0002 respectively).
The identified prognostic indices with their prognostic group could be used not only as a predictor of disease-free survival but also as a good predictor for the need to add adjuvant therapy in adenocarcinoma of the urinary bladder.
确定膀胱腺癌的工作独立预后因素及预后指数。同时研究根治性膀胱切除术后加用术后放疗对该预后指数的影响。
216例膀胱腺癌患者接受了根治性膀胱切除术及盆腔淋巴结清扫术,其中82例患者术后接受了放疗,134例未接受放疗。术后放疗(PORT)采用全盆腔照射,剂量为50 Gy分25次,在5周内完成,于术后4 - 10周开始。
全组5年无病生存率为44±4%。术后放疗使无病生存率从单纯膀胱切除术后的33±6%显著提高至PORT患者的58±6%(P = 0.002)。DFS的独立预后因素为病理分期、组织学亚型、淋巴结受累情况及术后放疗的应用。根据病理结果使用预后指数对患者进行分层可产生可识别的预后组。术后放疗在中、高风险指数组中显著提高了DFS(分别为p = 0.0004和0.0002)。
所确定的预后指数及其预后组不仅可作为无病生存的预测指标,还可作为膀胱腺癌是否需要加用辅助治疗的良好预测指标。